ArticleScientific reports2026
Antibacterial and anti-biofilm mechanisms of 1,8-cineole against colistin-resistant Acinetobacter baumannii: an integrated in vitro, gene expression, and in silico study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rise of colistin-resistant Acinetobacter baumannii (ColR Ab) poses a major clinical challenge, underscoring the urgent need for alternative antimicrobial agents. This study evaluated the antibacterial and anti-biofilm mechanisms of 1,8-cineole against ColR Ab using in vitro, transcriptional, and in silico approaches. Minimum inhibitory concentrations (MICs) and anti-biofilm activities were determined against three ColR Ab isolates. Membrane integrity was assessed via protein and nucleic acid leakage assays. Scanning electron microscopy (SEM) revealed bacterial morphology and biofilm structure, and expression of biofilm-associated genes was analyzed by qRT-PCR. Additionally, molecular docking analysis was employed to evaluate the binding affinity of 1,8-cineole against key target proteins of A. baumannii. The inhibition zone in the disk diffusion method and MIC were 10.3 ± 0.8 mm and 3.6 mg/mL, respectively. 1,8-cineole also caused significant protein and nucleic acid leakage and, at 4× MIC, significantly disrupted the mature biofilm structure. SEM confirmed bacterial cell membrane rupture, intracellular content leakage, and ultrastructural damage following treatment. qRT-PCR validation demonstrated that 1,8-cineole significantly downregulated the expression of the bfmR, bap, csuE, ompA, and pgaB, while abaI expression was not significantly affected. Molecular docking simulations predicted favorable binding of 1,8-cineole to quorum-sensing regulators AbaR and LuxR-family regulator. 1,8-cineole exhibits significant bactericidal and anti-biofilm activity against ColR Ab. Its mechanism of action may involve disruption of cell membrane integrity and potential interference with bacterial key quorum-sensing regulators. This study provides a theoretical basis for developing 1,8-cineole as a potential therapeutic strategy against ColR Ab infections.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.